Lantern Pharma Stock Price on May 6, 2024
| LTRN Stock | USD 4.55 0.46 9.18% |
If you're considering investing in Lantern Stock, it is important to understand the factors that can impact its price. As of today, the current price of Lantern Pharma stands at 4.55, as last reported on the 20th of February, with the highest price reaching 5.24 and the lowest price hitting 4.53 during the day. Lantern Pharma appears to be relatively risky, given 3 months investment horizon. Lantern Pharma has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13 % return per unit of risk over the last 3 months. By analyzing Lantern Pharma's technical indicators, you can evaluate if the expected return of 0.93% is justified by implied risk. Please exercise Lantern Pharma's Downside Deviation of 5.58, mean deviation of 5.23, and Risk Adjusted Performance of 0.1063 to check out if our risk estimates are consistent with your expectations.
Lantern Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Lantern |
Sharpe Ratio = 0.1255
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | LTRN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 7.39 actual daily | 65 65% of assets are less volatile |
Expected Return
| 0.93 actual daily | 18 82% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Lantern Pharma is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lantern Pharma by adding it to a well-diversified portfolio.
Related Headline
Lyra Therapeutics Headline on 6th of May 2024
Lyra Therapeutics shares downgraded after study misses endpo... by investing.com
Lyra Therapeutics shares downgraded after study misses endpoint
Lantern Pharma Valuation on May 6, 2024
It is possible to determine the worth of Lantern Pharma on a given historical date. On May 6, 2024 Lantern was worth 6.3 at the beginning of the trading date compared to the closed value of 6.85. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Lantern Pharma stock. Still, in general, we apply an absolute valuation method to find Lantern Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Lantern Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Lantern Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 5.57 | 6.37 | 5.57 | 6.15 | 189,711 | |
05/06/2024 | 6.30 | 7.21 | 6.24 | 6.85 | 156,751 |
| 6.90 | 7.02 | 6.23 | 6.42 | 108,571 |
| Backtest Lantern Pharma | | | Lantern Pharma History | | | Lantern Pharma Valuation | Previous | Next |
Lantern Pharma Trading Date Momentum on May 6, 2024
| On May 07 2024 Lantern Pharma was traded for 6.42 at the closing time. The top price for the day was 7.02 and the lowest listed price was 6.23 . The trading volume for the day was 108.6 K. The trading history from May 7, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 6.28% . The trading delta at closing time against the current closing price is 8.32% . |
Lantern Pharma Fundamentals Correlations and Trends
By evaluating Lantern Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Lantern Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Lantern financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Lantern Pharma Stock history
Lantern Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Lantern is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Lantern Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Lantern Pharma stock prices may prove useful in developing a viable investing in Lantern Pharma
Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. The company was incorporated in 2013 and is headquartered in Dallas, Texas. Lantern Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 14 people.
Lantern Pharma Stock Technical Analysis
Lantern Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Lantern Pharma Period Price Range
Low | February 20, 2025
| High |
0.00 | 0.00 |
Lantern Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Lantern Pharma February 20, 2025 Market Strength
Market strength indicators help investors to evaluate how Lantern Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Lantern Pharma shares will generate the highest return on investment. By undertsting and applying Lantern Pharma stock market strength indicators, traders can identify Lantern Pharma entry and exit signals to maximize returns
Lantern Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Lantern Pharma's price direction in advance. Along with the technical and fundamental analysis of Lantern Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Lantern to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1063 | |||
| Jensen Alpha | 1.01 | |||
| Total Risk Alpha | 0.8495 | |||
| Sortino Ratio | 0.1782 | |||
| Treynor Ratio | 4.18 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lantern Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Lantern Stock, please use our How to Invest in Lantern Pharma guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lantern Pharma. If investors know Lantern will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lantern Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Lantern Pharma is measured differently than its book value, which is the value of Lantern that is recorded on the company's balance sheet. Investors also form their own opinion of Lantern Pharma's value that differs from its market value or its book value, called intrinsic value, which is Lantern Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lantern Pharma's market value can be influenced by many factors that don't directly affect Lantern Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lantern Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lantern Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lantern Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.